Biofrontera Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.017 million compared to USD 0.032 million a year ago. Revenue was USD 8.9 million compared to USD 4.32 million a year ago. Net loss was USD 6.34 million compared to USD 2.57 million a year ago. Basic loss per share from continuing operations was USD 4.64 compared to USD 2.26 a year ago. Diluted loss per share from continuing operations was USD 4.64 compared to USD 2.26 a year ago.
For the nine months, sales was USD 0.052 million compared to USD 0.063 million a year ago. Revenue was USD 23.48 million compared to USD 18.53 million a year ago. Net loss was USD 23.66 million compared to net income of USD 2.15 million a year ago. Basic loss per share from continuing operations was USD 17.57 compared to basic earnings per share from continuing operations of USD 2.19 a year ago. Diluted loss per share from continuing operations was USD 17.57 compared to diluted earnings per share from continuing operations of USD 2.19 a year ago.